Senhwa Biosciences Signs Major Strategic MOU with Y Combinator-Backed AI Biotech Company CellType to Accelerate the Evolution of CX-4945 into Version 2.0 and Reshape the Global Immunotherapy Landscape
TAIPEI and SAN DIEGO, March 3, 2026 /PRNewswire/ -- Senhwa Biosciences, Inc. (TPEx: 6492), a clinical stage company focusing on development of first-in-class therapeutics for oncology, rare diseases, and infectious diseases, today announced the...
OPTIMUS TECHNOLOGIES AND MITSUI & CO. EXECUTE STRATEGIC MOU FOR GLOBAL DISTRIBUTION OF BIODIESEL SOLUTIONS
PITTSBURGH, Dec. 9, 2025 /PRNewswire/ -- Optimus Technologies, a leader in advanced biodiesel engine technology, today announced the signing of a Memorandum of Understanding (MOU) with Mitsui & Co., Ltd. ("Mitsui"), one of the world's most...